Bushra Zaman
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Graduate Research Assistant and Ph.D. Candidate
Also affiliated: Utah State University (2011–2024); Population Council (2010); Shahjalal University of Science and Technology (2024); University of Engineering and Technology Lahore (2025); North South University (2024); Gomal University (2025–2026); BRAC (2010); Pir Mehr Ali Shah Arid Agriculture University (2011–2017); University of Dhaka (2010); University of Arkansas Medical Center (2024); United States Agency for International Development (2010); University of Liberal Arts Bangladesh (2010); University of Malaya (2018); Gheorghe Asachi Technical University of Iași (2017); Save the Children (2010); Jagannath University (2018); Population Council (2010); Marie Stopes Society (2010); People's University of Medical and Health Sciences for Women (2022–2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Bushra Zaman's research focuses on the role of myeloid cells in ischemic retinopathies, investigating recent advances and unanswered questions in this area. Her work also includes the application of machine learning techniques, such as relevance vector and support vector machines, for data analysis and prediction. This includes applications in soil moisture estimation using remotely sensed data and the quantification of invasive species spread using high-resolution multispectral imagery acquired with unmanned aerial vehicles.
Zaman has also explored other areas, including corrosion investigations in industrial effluents and financial education for adolescents. Her scholarly contributions are reflected in an h-index of 9, with 44 total publications and 343 citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Rami Ahmad Shahror, Esraa Shosha, Abdelrahman Y. Fouda, and Paul H. Phillips.
Metrics
- h-index: 9
- Publications: 46
- Citations: 344
Positions
-
Graduate Research Assistant and Ph.D. Candidate 2023–presentUniversity of Arkansas for Medical Sciences Department of Neuroscience ORCID
Selected Publications
-
Clusterin as a therapeutic agent: Bridging the gap in brain and eye research (2026)
-
CD5L promotes efferocytosis and resolution of retinal ischemic injury (2026)
-
Molecular dynamics studies reveal the structural impacts of LRRK2 R1441C and LRRK2 D1994A mutations in Parkinson's disease (2024)
-
Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology (2024)
-
Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade (2024)
-
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions (2024)
Collaboration Network
Top Collaborators
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
- Clusterin as a therapeutic agent: Bridging the gap in brain and eye research
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- CD5L promotes efferocytosis and resolution of retinal ischemic injury
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade
- Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade
- Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade
- Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade
- Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade
Similar Researchers
Based on overlapping research topics